Completed OBSERVATIONAL NCT02053532

Functional Brain Imaging in PTSD

Sponsor: NYU Langone Health

Conditions Post-traumatic Stress Disorder (PTSD) Trauma

Interventions Positron emission tomography/magnetic resonance imaging

Updated 7 times since 2017 Last updated: Mar 2, 2016 Started: May 31, 2013 Primary completion: Mar 31, 2015 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02053532, this observational or N/A phase trial focuses on Post-traumatic Stress Disorder (PTSD) and Trauma and remains completed. Sponsored by NYU Langone Health, it has been updated 7 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2019 — Jan 2021 [monthly]

Completed
Jun 2018 — Jun 2019 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NYU Langone Health

Data source: NYU Langone Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States